ANGIOTENSIN CONVERTING ENZYMES (ACE) INHIBITORS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Angiotensin Converting Enzymes (ACE) Inhibitors, By Drugs
• Market Angiotensin Converting Enzymes (ACE) Inhibitors, By Indication
• Market Angiotensin Converting Enzymes (ACE) Inhibitors, By Route of Administration
• Market Angiotensin Converting Enzymes (ACE) Inhibitors, By Distribution Channel
• Market Angiotensin Converting Enzymes (ACE) Inhibitors, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Rising prevalence of hypertension
• Growing Research and Development Activities
• Increasing Awareness of Cardiovascular Health
• Restraints
• Patent Expirations
• Side Effects and Safety Concerns
• Side Effects and Safety Concerns
• Opportunities
• Increasing Awareness of Cardiovascular Health
• Personalized medicine
• Combination therapies
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launch/Approvals
• PEST Analysis
• PORTER’s Analysis
• Merger and Acquisition Scenario

4. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Drugs, 2021 - 2033, (USD Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022-2033
• Segment Trends
• Benazepril
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Perindopril
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Trandfolapril
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Captopril
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Enalapril
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Lisinopril
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Others (Ramipril, etc.)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Indication, 2021 - 2033, (USD Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022-2033
• Segment Trends
• Hypertension
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn )
• Coronary Artery Disease
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn )
• Heart Failure
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn )
• Chronic Kidney Disease
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn )
• Scleroderma
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
• Others (Migraine, etc.)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)

6. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Route of Administration, 2021 - 2033, (USD Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022-2033
• Segment Trends
• Oral
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Injectable
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Distribution Channel, 2021 - 2033, (USD Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022-2033
• Segment Trends
• Hospital Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Retail Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Online Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

8. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Region, 2021 - 2033, (USD Mn)

• Introduction
• Market Share Analysis, By Region, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, For Region, 2022 –2033
• Country Trends
• North America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
• U.S.
• Canada
• Europe
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
• Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
• GCC
• Israel
• North Africa
• Central Africa
• Rest of Middle East & Africa

9. Competitive Landscape

• Novartis AG
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Pfizer Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Merck & Co.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• AstraZeneca
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Sanofi
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Boehringer Ingelheim
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• GlaxoSmithKline
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Lupin Limited
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Torrent Pharmaceuticals Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Reddy's Laboratories Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Mylan
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

10. Section

• Research Methodology
• About us